NCCN Guidelines Version 3.2023
- Active (symptomatic) Myeloma
- Multiple Myeloma
- Smoldering (asymptomatic) Myeloma
- Solitary Plasmacytoma
Continuing Education
Recorded Presentation from the NCCN Pharmacy Updates: CAR-T Therapy in Multiple Myeloma
Monthly Oncology Tumor Boards: Management of Patients with Multiple Myeloma
How to Incorporate Immunotherapies in the Management of Multiple Myeloma
Archived Monthly Oncology Tumor Boards: Management of Patients with Multiple Myeloma
Translations
Arabic Version 5.2022
Chinese Version 5.2022
French Version 5.2022
German Version 5.2022
Italian Version 5.2022
Japanese Version 5.2022
Korean Version 5.2022
Polish Version 1.2023
Portuguese (Latin America) Version 5.2022
Romanian Version 1.2023
Russian Version 1.2023
Spanish (Latin America) Version 5.2022
Spanish (European Editions) Version 5.2022
Ukrainian Version 1.2023
Harmonized
English (Caribbean) Version 4.2018
English (Africa) Version 3.2023